{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:29:48Z","timestamp":1786494588195,"version":"build-2736575974"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes for Health","doi-asserted-by":"crossref","award":["5R25GM121231"],"award-info":[{"award-number":["5R25GM121231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes for Health","doi-asserted-by":"crossref","award":["F30AG079577"],"award-info":[{"award-number":["F30AG079577"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes for Health","doi-asserted-by":"crossref","award":["NIA R21AG059157"],"award-info":[{"award-number":["NIA R21AG059157"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes for Health","doi-asserted-by":"crossref","award":["NIA R01AG030142"],"award-info":[{"award-number":["NIA R01AG030142"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02097-2","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:17:07Z","timestamp":1780478227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuronal overexpression of Nrf2 reduces dystrophic neurites in 5XFAD Alzheimer\u2019s disease model mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Katherine R.","family":"Sadleir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen P.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidhanth","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makenna L.","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammaarah W.","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance L.","family":"Cepko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"9","key":"2097_CR1","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 2018;91(9):e859\u201366.","journal-title":"Neurology"},{"issue":"11","key":"2097_CR2","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2967\/jnumed.118.221697","volume":"60","author":"H Cho","year":"2019","unstructured":"Cho H, Choi JY, Lee HS, Lee JH, Ryu YH, Lee MS, et al. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study. J Nucl Med. 2019;60(11):1611\u201321.","journal-title":"J Nucl Med"},{"issue":"8","key":"2097_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, et al. Association of amyloid and Tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76(8):915\u201324.","journal-title":"JAMA Neurol"},{"issue":"6","key":"2097_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021;27(6):954\u201363.","journal-title":"Nat Med"},{"issue":"1","key":"2097_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9(1):119\u201328.","journal-title":"Lancet Neurol"},{"issue":"5","key":"2097_CR6","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, et al. Longitudinal tau PET in ageing and Alzheimer\u2019s disease. Brain. 2018;141(5):1517\u201328.","journal-title":"Brain"},{"issue":"11","key":"2097_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","volume":"19","author":"W Jagust","year":"2018","unstructured":"Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci. 2018;19(11):687\u2013700.","journal-title":"Nat Rev Neurosci"},{"key":"2097_CR8","doi-asserted-by":"crossref","unstructured":"La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524).","DOI":"10.1126\/scitranslmed.aau5732"},{"issue":"16","key":"2097_CR9","doi-asserted-by":"publisher","first-page":"eaaz2387","DOI":"10.1126\/sciadv.aaz2387","volume":"6","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Andersson E, Janelidze S, Ossenkoppele R, Insel P, Strandberg O, et al. Abeta deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer\u2019s disease. Sci Adv. 2020;6(16):eaaz2387.","journal-title":"Sci Adv"},{"issue":"11","key":"2097_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Scholl M, Strandberg O, et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2018;320(11):1151\u201362.","journal-title":"JAMA"},{"issue":"12","key":"2097_CR11","doi-asserted-by":"publisher","first-page":"e11170","DOI":"10.15252\/emmm.201911170","volume":"11","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Insel PS, Stomrud E, Janelidze S, Zetterberg H, Brix B, et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease. EMBO Mol Med. 2019;11(12):e11170.","journal-title":"EMBO Mol Med"},{"key":"2097_CR12","doi-asserted-by":"publisher","first-page":"103551","DOI":"10.1016\/j.nicl.2023.103551","volume":"41","author":"G Chen","year":"2024","unstructured":"Chen G, McKay NS, Gordon BA, Liu J, Joseph-Mathurin N, Schindler SE, et al. Predicting cognitive decline: which is more useful, baseline amyloid levels or longitudinal change? Neuroimage Clin. 2024;41:103551.","journal-title":"Neuroimage Clin"},{"issue":"s1","key":"2097_CR13","doi-asserted-by":"publisher","first-page":"S633","DOI":"10.3233\/JAD-179928","volume":"64","author":"EC Mormino","year":"2018","unstructured":"Mormino EC, Papp KV. Amyloid accumulation and cognitive decline in clinically normal older individuals: implications for aging and early Alzheimer\u2019s disease. J Alzheimers Dis. 2018;64(s1):S633\u201346.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2097_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21(4):306\u201318.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"2097_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/nan.12642","volume":"46","author":"D Boche","year":"2020","unstructured":"Boche D, Nicoll JAR. Invited review - understanding cause and effect in Alzheimer\u2019s pathophysiology: implications for clinical trials. Neuropathol Appl Neurobiol. 2020;46(7):623\u201340.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"2097_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-beta plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24(1):29\u201338.","journal-title":"Nat Med"},{"key":"2097_CR17","doi-asserted-by":"publisher","first-page":"12082","DOI":"10.1038\/ncomms12082","volume":"7","author":"T Li","year":"2016","unstructured":"Li T, Braunstein KE, Zhang J, Lau A, Sibener L, Deeble C, et al. The neuritic plaque facilitates pathological conversion of tau in an Alzheimer\u2019s disease mouse model. Nat Commun. 2016;7:12082.","journal-title":"Nat Commun"},{"issue":"17","key":"2097_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/jama.2021.3854","volume":"325","author":"GC Alexander","year":"2021","unstructured":"Alexander GC, Emerson S, Kesselheim AS. Evaluation of aducanumab for alzheimer disease: scientific evidence and regulatory review involving efficacy, safety, and futility. JAMA. 2021;325(17):1717\u20138.","journal-title":"JAMA"},{"issue":"8","key":"2097_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/d41573-024-00116-1","volume":"23","author":"A Mullard","year":"2024","unstructured":"Mullard A. FDA approves third anti-amyloid antibody for Alzheimer disease. Nat Rev Drug Discov. 2024;23(8):571.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2097_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/nep3.23","volume":"1","author":"J Liu","year":"2023","unstructured":"Liu J, van Beusekom H, Bu XL, Chen G, Henrique Rosado de Castro P, Chen X, et al. Preserving cognitive function in patients with Alzheimer\u2019s disease: the Alzheimer\u2019s disease neuroprotection research initiative (ADNRI). Neuroprotection. 2023;1(2):84\u201398.","journal-title":"Neuroprotection"},{"issue":"6","key":"2097_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41591-024-02977-w","volume":"30","author":"HRC Shanks","year":"2024","unstructured":"Shanks HRC, Chen K, Reiman EM, Blennow K, Cummings JL, Massa SM, et al. p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nat Med. 2024;30(6):1761\u201370.","journal-title":"Nat Med"},{"issue":"39","key":"2097_CR22","doi-asserted-by":"publisher","first-page":"15596","DOI":"10.1523\/JNEUROSCI.5195-12.2013","volume":"33","author":"AH Nagahara","year":"2013","unstructured":"Nagahara AH, Mateling M, Kovacs I, Wang L, Eggert S, Rockenstein E, et al. Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice. J Neurosci. 2013;33(39):15596\u2013602.","journal-title":"J Neurosci"},{"issue":"10","key":"2097_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamaneurol.2015.1807","volume":"72","author":"MH Tuszynski","year":"2015","unstructured":"Tuszynski MH, Yang JH, Barba D, U HS, Bakay RA, Pay MM, et al. Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease. JAMA Neurol. 2015;72(10):1139\u201347.","journal-title":"JAMA Neurol"},{"key":"2097_CR24","doi-asserted-by":"publisher","first-page":"175909141989978","DOI":"10.1177\/1759091419899782","volume":"12","author":"MS Brandes","year":"2020","unstructured":"Brandes MS, Gray NE. NRF2 as a therapeutic target in neurodegenerative diseases. ASN Neuro. 2020;12:1759091419899782.","journal-title":"ASN Neuro"},{"issue":"2","key":"2097_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","volume":"236","author":"K Itoh","year":"1997","unstructured":"Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236(2):313\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2097_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1101\/gad.13.1.76","volume":"13","author":"K Itoh","year":"1999","unstructured":"Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13(1):76\u201386.","journal-title":"Genes Dev"},{"issue":"11","key":"2097_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","volume":"10","author":"H Motohashi","year":"2004","unstructured":"Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004;10(11):549\u201357.","journal-title":"Trends Mol Med"},{"key":"2097_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","volume":"47","author":"TW Kensler","year":"2007","unstructured":"Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89\u2013116.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"15","key":"2097_CR29","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1093\/nar\/gks409","volume":"40","author":"BN Chorley","year":"2012","unstructured":"Chorley BN, Campbell MR, Wang X, Karaca M, Sambandan D, Bangura F, et al. Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res. 2012;40(15):7416\u201329.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2097_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11033-023-09021-z","volume":"51","author":"R Dhapola","year":"2024","unstructured":"Dhapola R, Beura SK, Sharma P, Singh SK, HariKrishnaReddy D. Oxidative stress in Alzheimer\u2019s disease: current knowledge of signaling pathways and therapeutics. Mol Biol Rep. 2024;51(1):48.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2097_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi M, Di Domenico F, Butterfield DA. Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev. 2024;104(1):103\u201397.","journal-title":"Physiol Rev"},{"issue":"25","key":"2097_CR32","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.1073\/pnas.1819541116","volume":"116","author":"G Bahn","year":"2019","unstructured":"Bahn G, Park JS, Yun UJ, Lee YJ, Choi Y, Park JS, et al. NRF2\/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer\u2019s models. Proc Natl Acad Sci U S A. 2019;116(25):12516\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2097_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","volume":"66","author":"CP Ramsey","year":"2007","unstructured":"Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, et al. Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol. 2007;66(1):75\u201385.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2097_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41467-021-27702-w","volume":"13","author":"Z Jiwaji","year":"2022","unstructured":"Jiwaji Z, Tiwari SS, Aviles-Reyes RX, Hooley M, Hampton D, Torvell M, et al. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Ass pathology. Nat Commun. 2022;13(1):135.","journal-title":"Nat Commun"},{"key":"2097_CR35","doi-asserted-by":"crossref","unstructured":"Uruno A, Matsumaru D, Ryoke R, Saito R, Kadoguchi S, Saigusa D et al. Nrf2 suppresses oxidative stress and inflammation in app knock-in Alzheimer\u2019s disease model mice. Mol Cell Biol. 2020;40(6).","DOI":"10.1128\/MCB.00467-19"},{"issue":"1","key":"2097_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13578-022-00918-z","volume":"12","author":"Y Yao","year":"2022","unstructured":"Yao Y, Ren Z, Yang R, Mei Y, Dai Y, Cheng Q, et al. Salidroside reduces neuropathology in Alzheimer\u2019s disease models by targeting NRF2\/SIRT3 pathway. Cell Biosci. 2022;12(1):180.","journal-title":"Cell Biosci"},{"issue":"24","key":"2097_CR37","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1093\/hmg\/ddx361","volume":"26","author":"C Branca","year":"2017","unstructured":"Branca C, Ferreira E, Nguyen TV, Doyle K, Caccamo A, Oddo S. Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet. 2017;26(24):4823\u201335.","journal-title":"Hum Mol Genet"},{"key":"2097_CR38","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1038\/ncomms4496","volume":"5","author":"C Jo","year":"2014","unstructured":"Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun. 2014;5:3496.","journal-title":"Nat Commun"},{"issue":"4","key":"2097_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","volume":"18","author":"A Cuadrado","year":"2019","unstructured":"Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019;18(4):295\u2013317.","journal-title":"Nat Rev Drug Discov"},{"key":"2097_CR40","doi-asserted-by":"crossref","unstructured":"Wu DM, Ji X, Ivanchenko MV, Chung M, Piper M, Rana P et al. Nrf2 overexpression rescues the RPE in mouse models of retinitis pigmentosa. JCI Insight. 2021;6(2).","DOI":"10.1172\/jci.insight.145029"},{"issue":"4","key":"2097_CR41","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1172\/JCI79735","volume":"125","author":"W Xiong","year":"2015","unstructured":"Xiong W, MacColl Garfinkel AE, Li Y, Benowitz LI, Cepko CL. NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage. J Clin Invest. 2015;125(4):1433\u201345.","journal-title":"J Clin Invest"},{"issue":"38","key":"2097_CR42","doi-asserted-by":"publisher","first-page":"16505","DOI":"10.1073\/pnas.0908397106","volume":"106","author":"K Kanninen","year":"2009","unstructured":"Kanninen K, Heikkinen R, Malm T, Rolova T, Kuhmonen S, Leinonen H, et al. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2009;106(38):16505\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2097_CR43","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/stem.1666","volume":"32","author":"V Karkkainen","year":"2014","unstructured":"Karkkainen V, Pomeshchik Y, Savchenko E, Dhungana H, Kurronen A, Lehtonen S, et al. Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity. Stem Cells. 2014;32(7):1904\u201316.","journal-title":"Stem Cells"},{"issue":"2","key":"2097_CR44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbrc.2009.01.063","volume":"380","author":"T Satoh","year":"2009","unstructured":"Satoh T, Harada N, Hosoya T, Tohyama K, Yamamoto M, Itoh K. Keap1\/Nrf2 system regulates neuronal survival as revealed through study of keap1 gene-knockout mice. Biochem Biophys Res Commun. 2009;380(2):298\u2013302.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2097_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.stem.2023.01.002","volume":"30","author":"E Salta","year":"2023","unstructured":"Salta E, Lazarov O, Fitzsimons CP, Tanzi R, Lucassen PJ, Choi SH. Adult hippocampal neurogenesis in Alzheimer\u2019s disease: a roadmap to clinical relevance. Cell Stem Cell. 2023;30(2):120\u201336.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2097_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/hipo.23474","volume":"33","author":"J Terreros-Roncal","year":"2023","unstructured":"Terreros-Roncal J, Flor-Garcia M, Moreno-Jimenez EP, Rodriguez-Moreno CB, Marquez-Valadez B, Gallardo-Caballero M, et al. Methods to study adult hippocampal neurogenesis in humans and across the phylogeny. Hippocampus. 2023;33(4):271\u2013306.","journal-title":"Hippocampus"},{"issue":"7939","key":"2097_CR47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41586-022-05491-6","volume":"612","author":"P Yuan","year":"2022","unstructured":"Yuan P, Zhang M, Tong L, Morse TM, McDougal RA, Ding H, et al. PLD3 affects axonal spheroids and network defects in Alzheimer\u2019s disease. Nature. 2022;612(7939):328\u201337.","journal-title":"Nature"},{"issue":"40","key":"2097_CR48","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"5","key":"2097_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nmeth.1318","volume":"6","author":"DG Gibson","year":"2009","unstructured":"Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA 3rd, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6(5):343\u20135.","journal-title":"Nat Methods"},{"issue":"3","key":"2097_CR50","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/nprot.2006.207","volume":"1","author":"JC Grieger","year":"2006","unstructured":"Grieger JC, Choi VW, Samulski RJ. Production and characterization of adeno-associated viral vectors. Nat Protoc. 2006;1(3):1412\u201328.","journal-title":"Nat Protoc"},{"key":"2097_CR51","doi-asserted-by":"crossref","unstructured":"Xue Y, Wang SK, Rana P, West ER, Hong CM, Feng H et al. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa. Elife. 2021;10.","DOI":"10.7554\/eLife.66240"},{"issue":"46","key":"2097_CR52","doi-asserted-by":"publisher","first-page":"11923","DOI":"10.1523\/JNEUROSCI.2795-06.2006","volume":"26","author":"Y Levites","year":"2006","unstructured":"Levites Y, Jansen K, Smithson LA, Dakin R, Holloway VM, Das P, et al. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. J Neurosci. 2006;26(46):11923\u20138.","journal-title":"J Neurosci"},{"issue":"7","key":"2097_CR53","doi-asserted-by":"publisher","first-page":"e101643","DOI":"10.1371\/journal.pone.0101643","volume":"9","author":"KR Sadleir","year":"2014","unstructured":"Sadleir KR, Eimer WA, Kaufman RJ, Osten P, Vassar R. Genetic inhibition of phosphorylation of the translation initiation factor eIF2alpha does not block Abeta-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer\u2019s disease. PLoS ONE. 2014;9(7):e101643.","journal-title":"PLoS ONE"},{"issue":"1","key":"2097_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00401-025-02888-1","volume":"149","author":"KR Sadleir","year":"2025","unstructured":"Sadleir KR, Gomez KP, Edwards AE, Patel AJ, Ley ML, Khatri AW, et al. Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer\u2019s disease model mice. Acta Neuropathol. 2025;149(1):51.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2097_CR55","doi-asserted-by":"publisher","first-page":"e0263332","DOI":"10.1371\/journal.pone.0263332","volume":"17","author":"KR Sadleir","year":"2022","unstructured":"Sadleir KR, Popovic J, Khatri A, Vassar R. Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis. PLoS ONE. 2022;17(2):e0263332.","journal-title":"PLoS ONE"},{"issue":"4","key":"2097_CR56","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205018666210713125333","volume":"18","author":"KR Sadleir","year":"2021","unstructured":"Sadleir KR, Popovoic J, Zhu W, Reidel CT, Do H, Silverman RB, et al. Pregabalin treatment does not affect amyloid pathology in 5XFAD mice. Curr Alzheimer Res. 2021;18(4):283\u201397.","journal-title":"Curr Alzheimer Res"},{"key":"2097_CR57","doi-asserted-by":"crossref","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1).","DOI":"10.14806\/ej.17.1.200"},{"issue":"10","key":"2097_CR58","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","volume":"38","author":"GH Putri","year":"2022","unstructured":"Putri GH, Anders S, Pyl PT, Pimanda JE, Zanini F. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinformatics. 2022;38(10):2943\u20135.","journal-title":"Bioinformatics"},{"key":"2097_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1073\/pnas.2111643118","volume":"118","author":"M Ahuja","year":"2021","unstructured":"Ahuja M, Ammal Kaidery N, Attucks OC, McDade E, Hushpulian DM, Gaisin A, et al. Bach1 derepression is neuroprotective in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2021;118:45.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2097_CR60","doi-asserted-by":"publisher","first-page":"103794","DOI":"10.1016\/j.redox.2025.103794","volume":"86","author":"DM Hushpulian","year":"2025","unstructured":"Hushpulian DM, Kaidery NA, Soni P, Poloznikov AA, Zakhariants AA, Razumovskaya AV, et al. Functional analysis of bipartite NRF2 activators that overcome feedback regulation for age-related chronic diseases. Redox Biol. 2025;86:103794.","journal-title":"Redox Biol"},{"key":"2097_CR61","doi-asserted-by":"publisher","first-page":"106150","DOI":"10.1016\/j.nbd.2023.106150","volume":"182","author":"R Mabrouk","year":"2023","unstructured":"Mabrouk R, Miettinen PO, Tanila H. Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals. Neurobiol Dis. 2023;182:106150.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"2097_CR62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","volume":"132","author":"KR Sadleir","year":"2016","unstructured":"Sadleir KR, Kandalepas PC, Buggia-Prevot V, Nicholson DA, Thinakaran G, Vassar R. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Abeta generation in Alzheimer\u2019s disease. Acta Neuropathol. 2016;132(2):235\u201356.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2097_CR63","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0006-8993(93)91063-X","volume":"625","author":"JH Su","year":"1993","unstructured":"Su JH, Cummings BJ, Cotman CW. Identification and distribution of axonal dystrophic neurites in Alzheimer\u2019s disease. Brain Res. 1993;625(2):228\u201337.","journal-title":"Brain Res"},{"issue":"5","key":"2097_CR64","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1007\/s12035-023-03736-7","volume":"61","author":"W Tsering","year":"2024","unstructured":"Tsering W, Prokop S. Neuritic plaques - gateways to understanding Alzheimer\u2019s disease. Mol Neurobiol. 2024;61(5):2808\u201321.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"2097_CR65","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1073\/pnas.87.6.2249","volume":"87","author":"H Arai","year":"1990","unstructured":"Arai H, Lee VM, Otvos L Jr., Greenberg BD, Lowery DE, Sharma SK, et al. Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci U S A. 1990;87(6):2249\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2097_CR66","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF00296369","volume":"81","author":"H Yamaguchi","year":"1991","unstructured":"Yamaguchi H, Nakazato Y, Kawarabayashi T, Ishiguro K, Ihara Y, Morimatsu M, et al. Extracellular neurofibrillary tangles associated with degenerating neurites and neuropil threads in Alzheimer-type dementia. Acta Neuropathol. 1991;81(6):603\u20139.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2097_CR67","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s43587-025-00823-3","volume":"5","author":"Y Cai","year":"2025","unstructured":"Cai Y, Kanyo J, Wilson R, Bathla S, Cardozo PL, Tong L, et al. Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer\u2019s disease. Nat Aging. 2025;5(3):504\u201327.","journal-title":"Nat Aging"},{"issue":"17","key":"2097_CR68","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1073\/pnas.88.17.7552","volume":"88","author":"P Cras","year":"1991","unstructured":"Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A. 1991;88(17):7552\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2097_CR69","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0306-4522(92)90265-4","volume":"48","author":"BJ Cummings","year":"1992","unstructured":"Cummings BJ, Su JH, Geddes JW, Van Nostrand WE, Wagner SL, Cunningham DD, et al. Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer\u2019s disease. Neuroscience. 1992;48(4):763\u201377.","journal-title":"Neuroscience"},{"issue":"11","key":"2097_CR70","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/alz.12546","volume":"18","author":"T Jorda-Siquier","year":"2022","unstructured":"Jorda-Siquier T, Petrel M, Kouskoff V, Smailovic U, Cordelieres F, Frykman S, et al. APP accumulates with presynaptic proteins around amyloid plaques: a role for presynaptic mechanisms in Alzheimer\u2019s disease? Alzheimers Dement. 2022;18(11):2099\u2013116.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2097_CR71","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","volume":"126","author":"PC Kandalepas","year":"2013","unstructured":"Kandalepas PC, Sadleir KR, Eimer WA, Zhao J, Nicholson DA, Vassar R. The Alzheimer\u2019s beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol. 2013;126(3):329\u201352.","journal-title":"Acta Neuropathol"},{"issue":"14","key":"2097_CR72","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1523\/JNEUROSCI.4396-06.2007","volume":"27","author":"J Zhao","year":"2007","unstructured":"Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O\u2019Connor T, et al. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer\u2019s disease pathogenesis. J Neurosci. 2007;27(14):3639\u201349.","journal-title":"J Neurosci"},{"issue":"1","key":"2097_CR73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13195-021-00805-8","volume":"13","author":"C Clark","year":"2021","unstructured":"Clark C, Lewczuk P, Kornhuber J, Richiardi J, Marechal B, Karikari TK, et al. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer\u2019s disease pathology and clinical disease progression. Alzheimers Res Ther. 2021;13(1):65.","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"2097_CR74","doi-asserted-by":"publisher","first-page":"e12921","DOI":"10.15252\/emmm.202012921","volume":"12","author":"M Suarez-Calvet","year":"2020","unstructured":"Suarez-Calvet M, Karikari TK, Ashton NJ, Lantero Rodriguez J, Mila-Aloma M, Gispert JD, et al. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in Abeta pathology are detected. EMBO Mol Med. 2020;12(12):e12921.","journal-title":"EMBO Mol Med"},{"key":"2097_CR75","doi-asserted-by":"crossref","unstructured":"Gratuze M, Chen Y, Parhizkar S, Jain N, Strickland MR, Serrano JR et al. Activated microglia mitigate Abeta-associated tau seeding and spreading. J Exp Med. 2021;218(8).","DOI":"10.1084\/jem.20210542"},{"issue":"1","key":"2097_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-024-02775-1","volume":"148","author":"N Jury-Garfe","year":"2024","unstructured":"Jury-Garfe N, Redding-Ochoa J, You Y, Martinez P, Karahan H, Chimal-Juarez E, et al. Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer\u2019s disease. Acta Neuropathol. 2024;148(1):15.","journal-title":"Acta Neuropathol"},{"key":"2097_CR77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/srep00019","volume":"1","author":"C Condello","year":"2011","unstructured":"Condello C, Schain A, Grutzendler J. Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition. Sci Rep. 2011;1:19.","journal-title":"Sci Rep"},{"issue":"28","key":"2097_CR78","doi-asserted-by":"publisher","first-page":"E3699","DOI":"10.1073\/pnas.1510329112","volume":"112","author":"S Gowrishankar","year":"2015","unstructured":"Gowrishankar S, Yuan P, Wu Y, Schrag M, Paradise S, Grutzendler J, et al. Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer\u2019s disease amyloid plaques. Proc Natl Acad Sci U S A. 2015;112(28):E3699\u2013708.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2097_CR79","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00401-011-0896-x","volume":"123","author":"R Sanchez-Varo","year":"2012","unstructured":"Sanchez-Varo R, Trujillo-Estrada L, Sanchez-Mejias E, Torres M, Baglietto-Vargas D, Moreno-Gonzalez I, et al. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer\u2019s mice hippocampus. Acta Neuropathol. 2012;123(1):53\u201370.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2097_CR80","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005;64(2):113\u201322.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2097_CR81","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1038\/s41598-020-71767-4","volume":"10","author":"JJ Fernandez-Valenzuela","year":"2020","unstructured":"Fernandez-Valenzuela JJ, Sanchez-Varo R, Munoz-Castro C, De Castro V, Sanchez-Mejias E, Navarro V, et al. Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer\u2019s disease model. Sci Rep. 2020;10(1):14776.","journal-title":"Sci Rep"},{"issue":"1","key":"2097_CR82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2990.1992.tb00760.x","volume":"18","author":"A Migheli","year":"1992","unstructured":"Migheli A, Attanasio A, Pezzulo T, Gullotta F, Giordana MT, Schiffer D. Age-related ubiquitin deposits in dystrophic neurites: an immunoelectron microscopic study. Neuropathol Appl Neurobiol. 1992;18(1):3\u201311.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2097_CR83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1750-1326-7-59","volume":"7","author":"M Torres","year":"2012","unstructured":"Torres M, Jimenez S, Sanchez-Varo R, Navarro V, Trujillo-Estrada L, Sanchez-Mejias E, et al. Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP\/PS1 hippocampus. Mol Neurodegener. 2012;7:59.","journal-title":"Mol Neurodegener"},{"issue":"17","key":"2097_CR84","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010;285(17):13107\u201320.","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"2097_CR85","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/brain\/awq341","volume":"134","author":"DS Yang","year":"2011","unstructured":"Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, et al. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease ameliorates amyloid pathologies and memory deficits. Brain. 2011;134(Pt 1):258\u201377.","journal-title":"Brain"},{"issue":"27","key":"2097_CR86","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease. J Neurosci. 2008;28(27):6926\u201337.","journal-title":"J Neurosci"},{"issue":"29","key":"2097_CR87","doi-asserted-by":"publisher","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","volume":"285","author":"A Jain","year":"2010","unstructured":"Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, et al. p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem. 2010;285(29):22576\u201391.","journal-title":"J Biol Chem"},{"issue":"4","key":"2097_CR88","doi-asserted-by":"publisher","first-page":"167086","DOI":"10.1016\/j.bbadis.2024.167086","volume":"1870","author":"H Huang","year":"2024","unstructured":"Huang H, Sharoar MG, Pathoulas J, Fan L, He W, Xiang R, et al. Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2024;1870(4):167086.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2097_CR89","doi-asserted-by":"publisher","first-page":"878303","DOI":"10.3389\/fnagi.2022.878303","volume":"14","author":"R Jiang","year":"2022","unstructured":"Jiang R, Shimozawa M, Mayer J, Tambaro S, Kumar R, Abelein A, et al. Autophagy impairment in app knock-in Alzheimer\u2019s model mice. Front Aging Neurosci. 2022;14:878303.","journal-title":"Front Aging Neurosci"},{"key":"2097_CR90","doi-asserted-by":"publisher","first-page":"829232","DOI":"10.3389\/fnagi.2022.829232","volume":"14","author":"W Dong","year":"2022","unstructured":"Dong W, Cui MC, Hu WZ, Zeng Q, Wang YL, Zhang W, et al. Genetic and molecular evaluation of SQSTM1\/p62 on the neuropathologies of Alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:829232.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2097_CR91","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1365-2990.2002.00394.x","volume":"28","author":"E Kuusisto","year":"2002","unstructured":"Kuusisto E, Salminen A, Alafuzoff I. Early accumulation of p62 in neurofibrillary tangles in Alzheimer\u2019s disease: possible role in tangle formation. Neuropathol Appl Neurobiol. 2002;28(3):228\u201337.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"2097_CR92","doi-asserted-by":"publisher","first-page":"10092","DOI":"10.1038\/s41598-022-13683-3","volume":"12","author":"M de la Cueva","year":"2022","unstructured":"de la Cueva M, Antequera D, Ordonez-Gutierrez L, Wandosell F, Camins A, Carro E, et al. Amyloid-beta impairs mitochondrial dynamics and autophagy in Alzheimer\u2019s disease experimental models. Sci Rep. 2022;12(1):10092.","journal-title":"Sci Rep"},{"issue":"1","key":"2097_CR93","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","volume":"8","author":"S Forner","year":"2021","unstructured":"Forner S, Kawauchi S, Balderrama-Gutierrez G, Kramar EA, Matheos DP, Phan J, et al. Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease. Sci Data. 2021;8(1):270.","journal-title":"Sci Data"},{"issue":"7","key":"2097_CR94","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A Unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276\u2013e9017.","journal-title":"Cell"},{"issue":"3","key":"2097_CR95","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566\u201381. e9.","journal-title":"Immunity"},{"issue":"3","key":"2097_CR96","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/dgd.12194","volume":"57","author":"E Matsunaga","year":"2015","unstructured":"Matsunaga E, Nambu S, Oka M, Tanaka M, Taoka M, Iriki A. Periostin, a neurite outgrowth-promoting factor, is expressed at high levels in the primate cerebral cortex. Dev Growth Differ. 2015;57(3):200\u20138.","journal-title":"Dev Growth Differ"},{"issue":"23","key":"2097_CR97","doi-asserted-by":"publisher","first-page":"9477","DOI":"10.1073\/pnas.0901844106","volume":"106","author":"Y Tao","year":"2009","unstructured":"Tao Y, Dai P, Liu Y, Marchetto S, Xiong WC, Borg JP, et al. Erbin regulates NRG1 signaling and myelination. Proc Natl Acad Sci U S A. 2009;106(23):9477\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2097_CR98","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ana.23641","volume":"72","author":"A Al-Saif","year":"2012","unstructured":"Al-Saif A, Bohlega S, Al-Mohanna F. Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol. 2012;72(4):510\u20136.","journal-title":"Ann Neurol"},{"issue":"6","key":"2097_CR99","doi-asserted-by":"publisher","first-page":"G1211","DOI":"10.1152\/ajpgi.00322.2010","volume":"299","author":"J Huang","year":"2010","unstructured":"Huang J, Tabbi-Anneni I, Gunda V, Wang L. Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am J Physiol Gastrointest Liver Physiol. 2010;299(6):G1211\u201321.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2097_CR100","doi-asserted-by":"publisher","first-page":"117575","DOI":"10.1016\/j.biopha.2024.117575","volume":"180","author":"S Liu","year":"2024","unstructured":"Liu S, Li X, Fan P, Gu Y, Yang A, Wang W, et al. The potential role of transcription factor sterol regulatory element binding proteins (SREBPs) in Alzheimer\u2019s disease. Biomed Pharmacother. 2024;180:117575.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"2097_CR101","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1016\/j.celrep.2017.11.069","volume":"21","author":"AB Ziegler","year":"2017","unstructured":"Ziegler AB, Thiele C, Tenedini F, Richard M, Leyendecker P, Hoermann A, et al. Cell-autonomous control of neuronal dendrite expansion via the fatty acid synthesis regulator SREBP. Cell Rep. 2017;21(12):3346\u201353.","journal-title":"Cell Rep"},{"issue":"3\u20134","key":"2097_CR102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000080023","volume":"18","author":"C Spell","year":"2004","unstructured":"Spell C, Kolsch H, Lutjohann D, Kerksiek A, Hentschel F, Damian M, et al. SREBP-1a polymorphism influences the risk of Alzheimer\u2019s disease in carriers of the ApoE4 allele. Dement Geriatr Cogn Disord. 2004;18(3\u20134):245\u20139.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2097_CR103","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1038\/ncomms8066","volume":"6","author":"KF Bell","year":"2015","unstructured":"Bell KF, Al-Mubarak B, Martel MA, McKay S, Wheelan N, Hasel P, et al. Neuronal development is promoted by weakened intrinsic antioxidant defences due to epigenetic repression of Nrf2. Nat Commun. 2015;6:7066.","journal-title":"Nat Commun"},{"key":"2097_CR104","doi-asserted-by":"publisher","first-page":"102830","DOI":"10.1016\/j.redox.2023.102830","volume":"65","author":"DC Levings","year":"2023","unstructured":"Levings DC, Pathak SS, Yang YM, Slattery M. Limited expression of Nrf2 in neurons across the central nervous system. Redox Biol. 2023;65:102830.","journal-title":"Redox Biol"},{"issue":"8","key":"2097_CR105","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, et al. The beta-Secretase BACE1 in Alzheimer\u2019s Disease. Biol Psychiatry. 2021;89(8):745\u201356.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"2097_CR106","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-021-00473-0","volume":"16","author":"C Claes","year":"2021","unstructured":"Claes C, Danhash EP, Hasselmann J, Chadarevian JP, Shabestari SK, England WE, et al. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u2019s disease. Mol Neurodegener. 2021;16(1):50.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"2097_CR107","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23(2):194\u2013208.","journal-title":"Nat Neurosci"},{"issue":"10","key":"2097_CR108","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/alz.12144","volume":"16","author":"Y Yao","year":"2020","unstructured":"Yao Y, Nzou G, Alle T, Tsering W, Maimaiti S, Trojanowski JQ, et al. Correction of microtubule defects within Abeta plaque-associated dystrophic axons results in lowered Abeta release and plaque deposition. Alzheimers Dement. 2020;16(10):1345\u201357.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2097_CR109","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-018-0291-3","volume":"13","author":"B Zhang","year":"2018","unstructured":"Zhang B, Yao Y, Cornec AS, Oukoloff K, James MJ, Koivula P, et al. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model. Mol Neurodegener. 2018;13(1):59.","journal-title":"Mol Neurodegener"},{"key":"2097_CR110","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.nbd.2016.12.021","volume":"105","author":"KR Brunden","year":"2017","unstructured":"Brunden KR, Lee VM, Smith AB 3rd, Trojanowski JQ, Ballatore C. Altered microtubule dynamics in neurodegenerative disease: therapeutic potential of microtubule-stabilizing drugs. Neurobiol Dis. 2017;105:328\u201335.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"2097_CR111","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1002\/alz.13875","volume":"20","author":"Y Yao","year":"2024","unstructured":"Yao Y, Muench M, Alle T, Zhang B, Lucero B, Perez-Tremble R, et al. A small-molecule microtubule-stabilizing agent safely reduces Abeta plaque and tau pathology in transgenic mouse models of Alzheimer\u2019s disease. Alzheimers Dement. 2024;20(7):4540\u201358.","journal-title":"Alzheimers Dement"},{"issue":"28","key":"2097_CR112","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.1523\/JNEUROSCI.5221-12.2013","volume":"33","author":"LF Gumy","year":"2013","unstructured":"Gumy LF, Chew DJ, Tortosa E, Katrukha EA, Kapitein LC, Tolkovsky AM, et al. The kinesin-2 family member KIF3C regulates microtubule dynamics and is required for axon growth and regeneration. J Neurosci. 2013;33(28):11329\u201345.","journal-title":"J Neurosci"},{"issue":"8","key":"2097_CR113","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.bpj.2017.09.015","volume":"113","author":"S Guzik-Lendrum","year":"2017","unstructured":"Guzik-Lendrum S, Rayment I, Gilbert SP. Homodimeric kinesin-2 KIF3CC promotes microtubule dynamics. Biophys J. 2017;113(8):1845\u201357.","journal-title":"Biophys J"},{"issue":"6","key":"2097_CR114","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1091\/mbc.E14-08-1332","volume":"27","author":"A Guillabert-Gourgues","year":"2016","unstructured":"Guillabert-Gourgues A, Jaspard-Vinassa B, Bats ML, Sewduth RN, Franzl N, Peghaire C, et al. Kif26b controls endothelial cell polarity through the Dishevelled\/Daam1-dependent planar cell polarity-signaling pathway. Mol Biol Cell. 2016;27(6):941\u201353.","journal-title":"Mol Biol Cell"},{"issue":"12","key":"2097_CR115","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/ajmg.a.40493","volume":"176","author":"MH Wojcik","year":"2018","unstructured":"Wojcik MH, Okada K, Prabhu SP, Nowakowski DW, Ramsey K, Balak C, et al. De novo variant in KIF26B is associated with pontocerebellar hypoplasia with infantile spinal muscular atrophy. Am J Med Genet A. 2018;176(12):2623\u20139.","journal-title":"Am J Med Genet A"},{"key":"2097_CR116","doi-asserted-by":"crossref","unstructured":"Castanho I, Yeganeh PN, Boix CA, Morgan SL, Mathys H, Prokopenko D et al. Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer\u2019s disease. bioRxiv. 2025.","DOI":"10.1101\/2025.01.13.632801"},{"issue":"12","key":"2097_CR117","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/nm1295-1291","volume":"1","author":"C Haass","year":"1995","unstructured":"Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, et al. The Swedish mutation causes early-onset Alzheimer\u2019s disease by beta-secretase cleavage within the secretory pathway. Nat Med. 1995;1(12):1291\u20136.","journal-title":"Nat Med"},{"key":"2097_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-10-1","volume":"10","author":"KR Sadleir","year":"2015","unstructured":"Sadleir KR, Eimer WA, Cole SL, Vassar R. Abeta reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Mol Neurodegener. 2015;10:1.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"2097_CR119","doi-asserted-by":"publisher","first-page":"10912","DOI":"10.18632\/aging.103305","volume":"12","author":"Z Long","year":"2020","unstructured":"Long Z, Chen J, Zhao Y, Zhou W, Yao Q, Wang Y, et al. Dynamic changes of autophagic flux induced by Abeta in the brain of postmortem Alzheimer\u2019s disease patients, animal models and cell models. Aging. 2020;12(11):10912\u201330.","journal-title":"Aging"},{"key":"2097_CR120","doi-asserted-by":"crossref","unstructured":"Saso L, Ates I, Tunc R, Yilmaz B, Gallorini M, Carradori S et al. Modulation of Nrf2 and mitochondrial function: pharmacological implications. Pharmaceuticals (Basel). 2025;18(11).","DOI":"10.3390\/ph18111698"},{"issue":"2","key":"2097_CR121","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/toxsci\/kfq072","volume":"115","author":"MJ Calkins","year":"2010","unstructured":"Calkins MJ, Vargas MR, Johnson DA, Johnson JA. Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicol Sci. 2010;115(2):557\u201368.","journal-title":"Toxicol Sci"},{"issue":"49","key":"2097_CR122","doi-asserted-by":"publisher","first-page":"17775","DOI":"10.1523\/JNEUROSCI.3049-12.2012","volume":"32","author":"L Gan","year":"2012","unstructured":"Gan L, Vargas MR, Johnson DA, Johnson JA. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci. 2012;32(49):17775\u201387.","journal-title":"J Neurosci"},{"issue":"31","key":"2097_CR123","doi-asserted-by":"publisher","first-page":"10507","DOI":"10.1523\/JNEUROSCI.1494-12.2012","volume":"32","author":"CM LaPash Daniels","year":"2012","unstructured":"LaPash Daniels CM, Austin EV, Rockney DE, Jacka EM, Hagemann TL, Johnson DA, et al. Beneficial effects of Nrf2 overexpression in a mouse model of Alexander disease. J Neurosci. 2012;32(31):10507\u201315.","journal-title":"J Neurosci"},{"issue":"1","key":"2097_CR124","doi-asserted-by":"publisher","first-page":"12552","DOI":"10.1038\/s41598-018-30675-4","volume":"8","author":"E Sigfridsson","year":"2018","unstructured":"Sigfridsson E, Marangoni M, Johnson JA, Hardingham GE, Fowler JH, Horsburgh K. Astrocyte-specific overexpression of Nrf2 protects against optic tract damage and behavioural alterations in a mouse model of cerebral hypoperfusion. Sci Rep. 2018;8(1):12552.","journal-title":"Sci Rep"},{"issue":"50","key":"2097_CR125","doi-asserted-by":"publisher","first-page":"13574","DOI":"10.1523\/JNEUROSCI.4099-08.2008","volume":"28","author":"MR Vargas","year":"2008","unstructured":"Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci. 2008;28(50):13574\u201381.","journal-title":"J Neurosci"},{"issue":"9","key":"2097_CR126","doi-asserted-by":"publisher","first-page":"113198","DOI":"10.1016\/j.isci.2025.113198","volume":"28","author":"X He","year":"2025","unstructured":"He X, Dando O, Qiu J. Nrf2 controls homeostatic transcriptional signatures and inflammatory responses in a cell-type specific manner in the adult mouse brain. iScience. 2025;28(9):113198.","journal-title":"iScience"},{"key":"2097_CR127","doi-asserted-by":"crossref","unstructured":"Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. Lipids and Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21(4).","DOI":"10.3390\/ijms21041505"},{"issue":"4","key":"2097_CR128","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/1567205014666170505101426","volume":"15","author":"A Zarrouk","year":"2018","unstructured":"Zarrouk A, Debbabi M, Bezine M, Karym EM, Badreddine A, Rouaud O, et al. Lipid biomarkers in Alzheimer\u2019s disease. Curr Alzheimer Res. 2018;15(4):303\u201312.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"2097_CR129","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-025-00803-6","volume":"20","author":"S He","year":"2025","unstructured":"He S, Xu Z, Han X. Lipidome disruption in Alzheimer\u2019s disease brain: detection, pathological mechanisms, and therapeutic implications. Mol Neurodegener. 2025;20(1):11.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"2097_CR130","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.chembiol.2025.02.003","volume":"32","author":"M Ebner","year":"2025","unstructured":"Ebner M, Frohlich F, Haucke V. Mechanisms and functions of lysosomal lipid homeostasis. Cell Chem Biol. 2025;32(3):392\u2013407.","journal-title":"Cell Chem Biol"},{"key":"2097_CR131","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ijbiomac.2022.01.117","volume":"200","author":"D Mrdenovic","year":"2022","unstructured":"Mrdenovic D, Pieta IS, Nowakowski R, Kutner W, Lipkowski J, Pieta P. Amyloid beta interaction with model cell membranes - what are the toxicity-defining properties of amyloid beta? Int J Biol Macromol. 2022;200:520\u201331.","journal-title":"Int J Biol Macromol"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02097-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:03:30Z","timestamp":1786493010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02097-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2097"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02097-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"184"}}